ARDELYX, INC. Debt Instrument, Interest Rate, Stated Percentage
ARDELYX, INC. (ARDX) had Debt Instrument, Interest Rate, Stated Percentage of 7.45% as of 2018-05-16, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateStatedPercentage · last filed 2020-11-05
- 2018-05-16: Debt Instrument, Interest Rate, Stated Percentage 7.45%.
| Period end | Debt Instrument, Interest Rate, Stated Percentage |
|---|---|
| 2018-05-16 | 7.45% 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |